Cattlemen for Cancer Research slates annual auction benefiting Keeling Center in Bastrop
Cattlemen for Cancer Research (CCR) will hold its 20th annual auction in Bastrop, Texas, Saturday, Oct. 20, at the Hills Prairie Livestock Auction Company, 1177 Hwy. 304. Proceeds benefit the Michale E. Keeling Center for Comparative Medicine and Research at The University of Texas MD Anderson Cancer Center.
Guests can enjoy a complimentary lunch as well as a silent auction, a children's arts and crafts tent, a washer pitching...
A Conversation With a Living Legend in Dallas to honor major champion Jordan Spieth
A Conversation With a Living Legend® in Dallas will honor PGA TOUR professional Jordan Spieth, Nov. 5 at the Hilton Anatole. CBS Sports'...
Poziotinib maintains high response rate against harmful lung cancer mutation
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide unprecedented response rates among...
Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases
In the largest study of long-term safety outcomes for patients with breast implants, researchers at The University of Texas MD Anderson Cancer Center have found that silicone implants are associated with some rare diseases, autoimmune disorders and other conditions; although a causative relationship has not been established. Results of the MD Anderson study are consistent with previously published studies that examined the safety of breast...
Rogers Award honors Padmanee Sharma, M.D., Ph.D., for excellence in research
Padmanee Sharma, M.D., Ph.D., is the 2018 recipient of the Julie and Ben Rogers Award for Excellence in Research at The University of Texas...
Study finds no difference in disease-free, overall survival for HER2+ breast cancer patients receiving treatment concurrently or sequentially
New research in women with HER2+ breast cancer found no difference in disease-free survival (DFS) and overall survival (OS) when receiving...
Poziotinib sustains high response rates against intractable lung cancer mutation
A drug revived by researchers at The University of Texas MD Anderson Cancer Center continues to provide high response rates among stage 4...